Heterogeneous programmed death-ligand 1 expression in gastric cancer: comparison of tissue microarrays and whole sections

BACKGROUND: Programmed death-ligand 1 (PD-L1) expression determines the eligibility for anti-PD-1 treatment in patients with advanced gastric cancer, but evidence indicates that PD-L1 staining is heterogeneous. Patients who are ineligible for radical surgery could be tested for PD-L1 expression with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Min, Huang, Dan, Zhang, Qiongyan, Weng, Weiwei, Tan, Cong, Qin, Guangqi, Jiang, Wenhua, Sheng, Weiqi, Wang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247123/
https://www.ncbi.nlm.nih.gov/pubmed/32489322
http://dx.doi.org/10.1186/s12935-020-01273-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247123/
https://www.ncbi.nlm.nih.gov/pubmed/32489322
http://dx.doi.org/10.1186/s12935-020-01273-0

Ejemplares similares